Replies to post #297 on Armata Pharmaceuticals, Inc. (ARMP)

[Seel]

I've actually put some thought into that in regards to APHB. I've wondered if - when this company releases a preclinical pr - investors are reminded of how very early in its development this company and its pipeline are - causing emotional dip of disappointment/impatience. My theory may have no basis in reality whatsoever - but its all I could come up with to explain such perplexing behavior.